Dimension Therapeutics Inc logo

DMTX - Dimension Therapeutics Inc News Story

$5.95 0.0  0.0%

Last Trade - 06/11/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £11.7m
Position in Universe th / 6709

BRIEF-Dimension board determines Ultragenyx's unsolicited proposal constitutes a "superior proposal"

Mon 2nd October, 2017 1:00pm
Oct 2 (Reuters) - Dimension Therapeutics Inc  DMTX.O  
    * Dimension board determines that Ultragenyx's unsolicited 
proposal to acquire dimension for $6.00 per share constitutes a 
"superior proposal" 
    * Dimension Therapeutics Inc - dimension board has not 
changed its recommendation in support of REGENXBIO transaction 
 
Source text for Eikon:  ID:nGNXOEPUKa  
Further company coverage:  DMTX.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.